Home › Trial NCT03219502
rTMS in Improving Neuropathy in Patients With Stage I-IV Cancer Who Have Received Oxaliplatin Chemotherapy
- Trial IDNCT03219502
- StatusActive Not Recruiting
- PhaseN/A
- Study typeInterventional
- SponsorM.D. Anderson Cancer Center
- Enrollment56
- Start date2017-07-10
- ConditionsMalignant Neoplasm · Neuropathy
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.